CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ 18,826	$ 15,183	$ 38,796	$ 27,063
General and administrative	5,777	4,951	11,794	9,489
Total operating expenses	24,603	20,134	50,590	36,552
Loss from operations	(24,603)	(20,134)	(50,590)	(36,552)
Other income (expense), net
Interest income	4,086	3,413	7,336	5,107
Change in fair value of contingent value right liability	800	0	800	0
Income tax expense	(232)		(232)
Other expense	(1)	0	(2)	0
Total other income (expense), net	4,653	3,413	7,902	5,107
Net loss	(19,950)	(16,721)	(42,688)	(31,445)
Other comprehensive income (loss):
Net unrealized losses on marketable securities	(86)	(111)	(280)	(111)
Comprehensive loss	$ (20,036)	$ (16,832)	$ (42,968)	$ (31,556)
Net loss per share, basic	$ (0.41)	$ (0.41)	$ (0.95)	$ (1.05)
Net loss per share, diluted	$ (0.41)	$ (0.41)	$ (0.95)	$ (1.05)
Weighted-average shares outstanding, basic	48,075,035	40,961,024	45,060,322	29,862,182
Weighted-average shares outstanding, diluted	48,075,035	40,961,024	45,060,322	29,862,182